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Abstract 
BACKGROUND: Post-thoracotomy pain syndrome (PTPS) can be challenging to treat.  
AIM: This study aimed to evaluate the efficacy of perioperative pregabalin in the prevention of acute and chronic 
post-thoracotomy pain.  
METHODS: Sixty patients scheduled for thoracotomy for oncologic surgeries were randomly allocated to one of 
two groups; Pregabalin and Control. In the Pregabalin group, pregabalin 150 mg was administered one hour 
before thoracotomy and 12 hours later, then every 12 hours for five days. Pain intensity was assessed using the 
Visual Analogue Scale (VAS) at rest (VAS-R) and dynamic (VAS-D) in the ICU and during the next four days. 
Morphine consumption and the frequency of side effects were recorded. Assessment of PTPS was done using the 
Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale at 1, 2, and 3 months.  
RESULTS: The VAS-R and VAS-D scores and the total morphine consumption were significantly lower in 
Pregabalin group during days 0 through 4. Neuropathic pain, allodynia, and hyperalgesia were significantly lower 
in Pregabalin group after 1, 2, and 3 months.  
CONCLUSION: Pregabalin is effective in the reduction of chronic neuropathic pain at 1, 2, and 3 months after 
thoracotomy and it also reduces pain and opioid consumption during the acute postoperative period with few 
adverse effects. 
 
 
Introduction 
 
Thoracotomy is recognised as one of the 
most painful surgical procedures [1]. Studies have 
shown that high levels of acute postoperative pain are 
associated with an increase in the likelihood of chronic 
pain [2]. The severity of acute postoperative pain has 
been linked to the development of persistent 
postoperative pain [3]. 
Post-thoracotomy pain syndrome (PTPS) is a 
common condition; its prevalence has been reported 
to reach 80% [4]. It is defined as pain that recurs or 
persists along a thoracotomy scar at least two months 
after the surgical procedure [5]. 
In general, postoperative pain after 
thoracotomy is burning and stabbing pain and shares 
many features of neuropathic pain [6]. It was found 
that tissue damage leads to sensitisation of dorsal 
horn neurons, which causes hyperalgesia or allodynia. 
This course may contribute to chronification of pain. 
Therefore, initiating analgesic treatment before tissue 
damage can reduce hyperexcitability of dorsal horn 
neurons and central sensitisation [7]. Hence, drugs 
that reduce postoperative hyperalgesia and control 
acute postoperative pain may be of clinical interest [8]. 
Pregabalin is one of these drugs that can 
reduce the excitability of the dorsal horn neurons. It is 
a γ-aminobutyric acid analogue that binds to α2-δ 
subunits of the voltage-gated calcium channels in the 
central nervous system [9]. It was first introduced as a 
potent anticonvulsant and anxiolytic drug [10]. 
Pregabalin is recommended as a first-line treatment 
for neuropathic pain conditions [11]. Because of its 
ability to block presynaptic voltage-gated calcium 
channels implicated in central sensitisation, 
perioperative use of pregabalin could be valuable in 
preventing the development of chronic pain [12], [13]. 
It has been successfully used perioperatively for 
controlling neuropathic pain during knee and 
laparoscopic surgery; therefore, similar positive 
results are expected for intercostal neuralgia in post-
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thoracotomy pain [14].  
The purpose of this study was to investigate 
the safety and efficacy of perioperative administration 
of pregabalin to control intercostal neuralgia after 
thoracotomy. 
 
 
Patients and Methods 
 
The study included 60 ASA physical status I 
and II patients between 25 and 60 years of age 
scheduled for elective open thoracotomy for thoracic 
oncologic surgeries. They were recruited from the 
National Cancer Institute, Cairo University from 
January 2017 to February 2018. The study was 
approved by the local ethical committee, and every 
patient provided an informed written consent to 
participate in the study. 
Patients with renal insufficiency, history of 
congestive heart failure, major psychiatric disorder, 
body mass index > 40 kg/m², weight < 50 kg, pre-
existing chronic pain in proposed surgical area or 
elsewhere requiring chronic analgesic use, 
hypersensitivity to opioids, tumors extending into 
chest wall, previous ipsilateral thoracotomy, chest 
tube in situ at time of surgery, patients on 
anticonvulsants, patients planned for postoperative 
ventilation, or those who cannot use patient-controlled 
analgesia (PCA) were excluded from the study.  
Preoperatively patients were instructed how to 
use a visual analogue scale (VAS) (0 = no pain, 10 = 
worst pain) to express pain and use of the PCA 
device. Patients were randomly allocated to one of 
two equal groups. Pregabalin Group received 
pregabalin capsules, 150 mg (Lyrica, Pfizer, Egypt) 
while the Control group received placebo capsules 
(multivitamin capsules). A treatment schedule in the 
two groups was one capsule one hour before 
thoracotomy, 12 hours following operation (day zero 
postoperative), and then twice a day for 5 
postoperative days.  
All patients were premedicated with 
midazolam 0.05 mg/kg IV 30 minutes before the 
surgical procedure. A crystalloid IV infusion was 
established, and the baseline means arterial blood 
pressure (MAP), heart rate (HR), and peripheral 
oxygen saturation (SO₂) were recorded. Anaesthesia 
was induced with fentanyl 2 μg/kg and propofol 2 
mg/kg and atracurium 0.5 mg/kg IV and maintained 
with sevoflurane (2-3 vol%) and fresh gas flow rate of 
2 L/min in combination with 50% oxygen/air. After 
endotracheal intubation, lungs were mechanically 
ventilated to maintain the end-expiratory CO₂ values 
between 32-36 mm Hg, then morphine 0.1 mg/kg was 
administered IV. With skin closure, the residual 
neuromuscular blockade was antagonised with IV 
neostigmine 0.04 mg/kg and atropine 0.02 mg/kg. 
Ondansetron 4 mg IV was given to all patients. 
Patients were then transferred to the intensive 
care unit (ICU) to start using the PCA device for 5 
days (Accufuser PLUS M5015L WOO YOUNG 
MEDICAL CO.LTD, Korea). The PCA device 
contained a volume of 300 ml (60 mg morphine + 60 
mg ketorolac + 2 mg Garnitryl). The basal rate was 
5.0 ml/hr, and bolus 1.0 ml (0.2 mg) with a lockout 
interval of 15 min (limit of 1.8 mg/hr) and total opioid 
consumption were recorded. The pain was assessed 
using a VAS score at 0, and after 4, 8, 12, 16, 20, and 
24 hours. The mean of VAS at rest (VAS-R) and 
during a cough or with movement or cough (dynamic) 
(VAS-D) were recorded. The occurrence of 
postoperative side effects (confusion, dizziness, 
headache, dry mouth, nausea, vomiting, and pruritus 
were recorded at follow up intervals.  
Assessment of the incidence of chronic post-
thoracotomy pain syndrome and pain quality 
(neuropathic versus other) using Leeds Assessment 
of Neuropathic Symptoms and Signs (LANSS) scale 
was done at 1, 2, and 3 months postoperatively. 
Patients who suffered from symptoms of neuropathic 
pain, allodynia or hyperalgesia at first month received 
pregabalin 150 mg BID and were reassessed at 2
nd
 
and 3
rd
 month. The LANSS pain scale consists of five 
items that document self-reported pain symptoms and 
two items that document the findings of a simple 
clinical examination conducted by the healthcare 
professional to assess the presence of allodynia and 
pin-prick threshold [15]. A LANSS score of 12 or more 
is an indication of chronic neuropathic pain; allodynia 
(assessed by gentle rubbing of the operated site by a 
piece of cotton) and hyperalgesia (gently applied 
pressure from the fingertip). 
 
Statistical Analysis 
Statistical Analysis was performed using 
SPSS 15.0 for Windows. Numerical data were 
expressed as mean and standard deviation or median 
and range as appropriate. Qualitative data were 
expressed as frequency and percentage. Chi-square 
test (Fisher’s exact test) was used to examine the 
relation between qualitative variables. For quantitative 
data, a comparison between two groups was made 
using independent sample t-test or Mann-Whitney 
test. A p-value of ˂ 0.05 was accepted as statistically 
significant. 
 
 
Results 
 
Demographic data, duration of anaesthesia 
and surgery were comparable between groups (Table 
1).  
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Table 1: Demographic data  
Variables  Pregabalin 
(n = 30) 
Control 
(n = 30) 
p value 
Age (years) 46.9 ± 10.1 41.0 ± 14.5 0.072 
Weight (kg) 83.1 ± 9.9 77.1 ± 15.5 0.078 
Height (cm) 176 ± 9 173 ± 11 0.246 
Gender (M/F) 22/8 21/9 1.0 
Duration of surgery (minutes) 188 ± 25 178 ± 10 0.066 
Duration of anesthesia (minutes) 220 ± 28 211 ± 11 0.910 
Type of surgery    
Lobectomy 9 3 0.117 
Pneumonectomy 11 17 
Pleurectomy 10 10 
Data are expressed as mean ± SD (standard deviation), or number as appropriate; P value 
< 0.05 is considered significant; There were no statistical differences among groups. 
 
VAS-R and VAS-D were significantly lower in 
Pregabalin group at 0, 6, 18 and 24 hours but were 
comparable between groups at 12 hours (Table 2).  
Table 2: VAS-R and VAS-D. Data are expressed as mean ± SD 
 Pregabalin 
(n = 30) 
Control 
(n = 30) 
p value 
0 hour VAS-R 
VAS-D 
2.9 ± 0.7 
6.0 ± 0.7 
3.5 ± 1.0 
6.6 ± 1.0 
0.022*
 
0.016*
 
6 hours VAS-R 
VAS-D 
3.3 ± 0.9 
4.4 ± 0.9 
3.8 ± 0.7 
5.0 ± 0.7 
0.042*
 
0.023*
 
12 hours VAS-R 
VAS-D 
2.6 ± 0.8 
3.5 ± 0.8 
3.0 ± 0.9 
3.9 ± 0.9 
0.125 
0.209 
18 hours VAS-R 
VAS-D 
2.1 ± 0.6 
3.3 ± 0.7 
2.6 ± 0.8 
3.8 ± 0.9 
0.022*
 
0.020*
 
24 hours VAS-R 
VAS-D 
1.6 ± 0.6 
3.1 ± 0.7 
2.0 ± 0.6 
3.5 ± 0.8 
0.037*
 
0.039* 
Data are expressed as mean ± SD (standard deviation); VAS-R = visual analogue score at 
rest; VAS-D = visual analogue score dynamic (during movement); * P value < 0.05 is 
considered significant. 
 
The mean VAS-R and VAS-D during 24 hours 
on days 1, 2, 3 and 4 were significantly lower in 
Pregabalin group. There was no significant difference 
between groups in days 5 and 6 (Table 3).  
Table 3: Mean of VAS-R and VAS-D during postoperative days 
1, 2, 3, 4, 5 and 6 
 Pregabalin 
(n = 30) 
Control 
(n = 30) 
p value 
Day 1 VAS-R 
VAS-D 
2.1 ± 0.7 
4.1 ± 1.0 
2.5 ± 0.6 
4.8 ± 0.8 
0.047*
 
0.014* 
Day 2 VAS-R 
VAS-D 
2.0 ± 0.8 
3.1 ± 1.0 
2.5 ± .8 
3.8 ± 0.8 
0.031* 
0.021* 
Day 3 VAS-R 
VAS-D 
1.4 ± 0.5 
2.5 ± 0.5 
1.8 ± 0.6 
2.9 ± 0.7 
0.027* 
0.043* 
Day 4 VAS-R 
VAS-D 
2.4 ± 0.7 
3.3 ± 0.7 
2.8 ± 0.8 
3.7 ± 0.8 
0.022* 
0.029* 
Day 5  
 
VAS-R 
VAS-D 
2.8 ± 0.8 
3.6 ± 0.8 
2.9 ± 0.8 
3.8 ± 0.6 
0.981 
0.509 
Day 6 
 
VAS-R 
VAS-D 
1.8 ± 0.6 
3.0 ± 0.8 
2.2 ± 1.1 
3.5 ± 1.2 
0.163 
0.197 
Data are expressed as mean ± SD (standard deviation); VAS-R = visual analogue score at 
rest; VAS-D = visual analogue score dynamic (during movement); * P value < 0.05 is 
considered significant. 
 
Total morphine consumption during the 
postoperative period was significantly lower in 
Pregabalin group (Table 4).  
Table 4: Total daily morphine consumption in (mg) with PCA 
device from day 0 to day 4 in the two studied groups 
 Pregabalin 
(n=30) 
Control 
(n=30) 
p value 
Day 1 34.8±2.2 35.9±1.3 0.028* 
Day 2 30.9±2.7 32.3±2.2 0.033* 
Day 3 28.3±2.2 29.6±2.0 0.022* 
Day 4 26.4±2.0 27.5±1.9 0.035* 
Data are expressed as mean ± SD (standard deviation); * P value < 0.05 is considered 
significant. 
 
The frequency of neuropathic pain, allodynia, 
and hyperalgesia at the site of operation were 
significantly lower in Pregabalin group after 1, 2- and 
3-months post-thoracotomy (Table 5).  
Table 5: The proportion of post-thoracotomy chronic pain after 
1, 2 and 3 months 
 Pregabalin 
(n = 30) 
Control 
(n = 30) 
p value 
Neuropathic pain    
At 1 month 3 (10.0%) 11 (36.7%) 0.015* 
At 2 months 1 (3.3%) 8(26.7%) 0.011* 
At 3 months 0 (0.0%) 5 (16.7%) 0.052* 
Allodynia    
At 1 month 5 (16.7%) 13 (43.3%) 0.024* 
At 2 months 2 (6.7%) 9 (30.0%) 0.020* 
At 3 months 0 (0.0%) 6 (20.0%) 0.024* 
Hyperalgesia    
At 1 month 3 (10.0%) 11 (36.7%) 0.015* 
At 2 months 2 (6.7%) 9 (30.0%) 0.020* 
At 3 months 0 (0.0%) 7 (23.3%) 0.011* 
Data are expressed as number (proportion); * P value < 0.05 is considered significant. 
 
Adverse effects were comparable between 
groups (Table 6). No cases of respiratory depression 
were recorded. 
Table 6: Incidence of Adverse Effects 
 Pregabalin 
(n=30) 
Control 
(n=30) 
p value 
Confusion 2 (6.7%) 4 (13.3%) 0.671 
Dizziness 5 (16.7%) 8 (26.7%) 0.347 
Headache 3 (10.0%) 2 (6.7%) 1.000 
Dry Mouth 1 (3.3%) 2 (6.7%) 1.000 
Nausea 8 (26.7%) 3 (10.0%) 0.095 
Vomiting 3 (10.0%) 1 (3.3%) 0.612 
Pruritus 3 (10.0%) 1 (3.3%) 0.612 
Data are expressed as number (proportion); * P value < 0.05 is considered significant. 
 
 
 
Discussion 
 
The results of this study demonstrated that 
perioperative administration of pregabalin reduced 
pain intensity and morphine consumption during the 
first postoperative 4 days in patients having oncologic 
surgery through a thoracotomy incision. The 
frequency of chronic neuropathic pain, allodynia and 
hyperalgesia was significantly reduced in pregabalin 
group one, two, and three months after surgery. The 
frequency of side effects like confusion, dizziness, 
headache, and dry mouth was not increased in the 
pregabalin group. 
In this study, the first dose of pregabalin 150 
mg is given 1 hour before surgery to provide 
analgesia immediately after surgery. The idea of the 
study was to test whether pregabalin will have better 
control of acute postoperative pain aiming at 
prevention of pain chronification [16]. The proposed 
action of pregabalin was suppression of 
hyperexcitability of the dorsal horn neurons and 
neuroplastic changes after surgery. Pregabalin has 
predominantly inhibitory effect during the first 24 
hours; then it has an excitatory effect for 5 days after 
surgery [17]. The daily pregabalin dose of 300 mg 
used in this study was based on previous studies [14], 
[15].  
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In the current study, on postoperative day 0, 
the pain intensity was less in pregabalin group 
throughout the day. This can be contributed to the 
synergistic analgesic effect of pregabalin with 
morphine, which led to a decrease in opioid 
consumption in the first day. After that, pain intensity 
was lower in the pregabalin group from day 1 through 
day 4 with reduced total morphine consumption.  
Previous studies reported similar results in 
different after different surgical procedures. 
Bornemann-Cimenti et al., [7] found that the 
preoperative administration of 300 mg pregabalin in 
patients undergoing transperitoneal nephrectomy 
reduces postoperative opioid consumption by 33% 
within the first 48 h. In video-assisted thoracoscopic 
surgery, a single dose of pregabalin 150 mg 
preoperatively was effective in reducing the pain 
intensity and need for additional analgesic drugs [19]. 
Another study reported adequate postoperative pain 
control after robot-assisted endoscopic thyroidectomy 
using one dose of 150 mg 1 h before surgery and 
another dose 12 hours after [20]. Similar results were 
reported [21]. 
In the current study, perioperative 
administration of pregabalin decreased the frequency 
of chronic neuropathic pain after one, two and three 
months after surgery. Similar results were obtained 
concerning allodynia and hyperalgesia in the 
pregabalin group. 
By these findings, Fawzi and El-Tohamy 
found that perioperative pregabalin reduces the 
incidence of chronic post-thoracotomy pain at 3 and 6 
months from 60 and 40% to 10 and 6.7%, respectively 
[22]. 
On the contrary, Brulotte et al. concluded that 
pregabalin did not reduce the incidence of PTPS. 
However, among pregabalin users who developed 
PTPS, pain intensity was less marked, required 
significantly fewer analgesics, and presented 
significantly less neuropathic characteristics 
compared to patients in the placebo group 3 months 
after surgery [13]. 
The limitation of our study is a relatively small 
sample size and short follow up, which is only three 
months. In conclusion, perioperative use of pregabalin 
reduces pain and opioid consumption during the acute 
postoperative period and the incidence of chronic pain 
at two and three months after thoracotomy.  
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